Narix Pharmaceuticals

Narix Pharmaceuticals was a specialty pharmaceutical company focused on the development of drug products utilizing proprietary nasal delivery technologies. The company aimed to enhance the delivery of both generic and branded therapeutics by leveraging the nasal mucosa for rapid absorption and improved bioavailability. Based in Morgantown, West Virginia, Narix developed a pipeline of products designed to address unmet needs in respiratory and central nervous system disorders. In October 2007, the company was acquired by Mylan Inc., which integrated Narix's technology and expertise into its global respiratory and specialty drug platform.